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Exercise and Lifestyle Therapy Improves Weight Maintenance 
in Young People with Psychosis: A Service Evaluation
INTRODUCTION
Young people with psychosis typically have higher 
rates of premature cardiovascular disease and 
metabolic disorders compared to non-psychotic peers. 
This has been primarily due to a sedentary lifestyle, 
poor diet composition, misuse of harmful substances 
and higher rates of obesity and smoking. When 
prescribed obesogenic antipsychotic medication, a 
weight gain of >12 kg within 2 years is typical.
PURPOSE: To examine the benefits of a 12 wk 
exercise and lifestyle intervention entitled ‘Supporting 
Health and Promoting Exercise’ (SHAPE) for young 
people recently diagnosed with psychosis. 
METHODS
Participants (n=26; 8 females; mean age 27.7 ± 5.1) 
engaged in weekly 45’ education sessions on healthy 
lifestyle behaviors, including:
• managing anxiety and depression,
• mindfulness and relaxation training,
• substance misuse,
• smoking cessation,
• healthy eating and nutritional advice,
• dental and sexual health care.
This was followed by a 45’ exercise session including 
activities such as circuit and resistance training, yoga, 
and badminton, led by qualified exercise instructors. 
Anthropometric data were measured at baseline, 12 wk 
and 12 month post-intervention. Lifestyle behaviors and 
clinical measurements, including resting heart rate, 
blood pressure, total cholesterol, triglycerides, HbA1c 
and prolactin, were assessed at baseline and 12 
months post-intervention as part of their routine clinical 
care plan. Significant differences over time were 
assessed using Paired Sample t-tests .
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Variable N Baseline 12 months Mean Change P
BMI (kg.m2) 16 31.4 (8.5) 31.5 (9.0) 0.1 (2.5) 0.89
Waist 
circumference (cm) 
♂ 7
♀ 7
100.2 (23.3)
90.7 (13.3)
103.5 (27.5)
90. 7 (14.4)
3.3 (8.0)
-0.04 (5.2)
0.32
0.98
Systolic blood 
pressure (mm Hg)
15 122.4  (17.0) 125.2 (17.0) 2.8 (15.3) 0.49 
Diastolic blood 
pressure (mm Hg)
15 78.9 (9.2) 79.4 (9.4) 0.5 (9.5) 0.85
Resting heart rate 
(beats.min-1)
13 84.7 (21.4) 85.5 (21.3) 0.8 (18.4) 0.88
Total cholesterol 
(mmol.L-1)
9 4.4 (1.0) 4.3 (1.0) -0.2 (0.7) 0.48
Triglycerides 
(mmol.L-1)
4 2.3 (1.9) 2.0 (2.0) -0.4 (1.5) 0.64
HbA1C (mmol.mol) 7 31.8 (13.3) 37.7 (9.7) 5.9 (11.4) 0.22
Prolactin (mIU/L-1) 6 852.0 (707.3) 371.3 (239.1) -480.7 (595.3) 0.11 
RESULTS
SHAPE participants (n=26) presented with first episode psychosis 
(n=11), schizophrenia (n=11), bipolar disorder (n=2), at risk mental 
state (n=1), and persistent delusion disorder (n=1) of which 52% 
were prescribed highly obesogenic antipsychotic medications 
(Clozapine and Olanzepine).
• Mean baseline data suggests participants were at an increased 
health risk due to elevated values in mean BMI (70% were 
overweight or obese), waist circumference, resting heart rate, and 
triglycerides (see Table 1 & 2). Over 50% reported smoking daily 
and 85% had elevated resting blood pressure (>120/80 mm Hg).
• At 12 wk post-intervention, no changes were observed in mean 
BMI or waist circumference (see Table 1); 19 participants either 
maintained (mean 0.5 kg: range ± 2 kg) or decreased (mean -5.7 
kg: range 2-7 kg) weight; 7 participants increased weight (mean 
4.9 kg: range 2.0-9.6 kg). 
• At 12 month post-intervention (n=16), no change was evident in 
mean BMI, waist circumference, or any other clinical variable (see 
Table 2). Positive impacts on lifestyle behaviors included 7 
participants eating ~400g of fruit/vegetables daily, 2 ceased 
substance use, 2 ceased alcohol use, 4 ceased smoking and 5 
were less sedentary. 
Table 1. Comparison of anthropometric measurements at baseline, 12 
weeks and 12 months.
Table 2. Comparison of cardiometabolic markers at baseline and 12 
months post-intervention.
CONCLUSION
At the start of the programme, participants were already at an 
increased risk for cardiometabolic disorders. Findings suggest that 
SHAPE supported young people with psychosis to:
• attenuate their physical health risk following a 12 wk exercise and 
lifestyle intervention which were sustained at 12 months follow up.
• make positive lifestyle behavior changes leading to sustained 
improvements in weight maintenance and physical health.
Variable
Baseline
(n=26)
12 wk 
post
(n=26)
Baseline to 
12 wk post
12 mo
post
(n=16)
Baseline to 
12 mo post
(n=16)
Body mass 
(kg)
94.4 (23.1) 95.1 (23.4)
t = 0.81 
p = 0.43
94.8 (27.9)
t = 0.05
p = 0.96
BMI (kg.m2) 30.7 (7.2) 31.0 (7.4)
t = 0.97 
p = 0.34
31.5 (9.0)
t = 0.14 
p = 0.89
Waist 
circumference 
(cm)
98.1 (17.0) 99.2 (16.8)
t = 0.76
p = 0.43
97.1 (22.1)
t = 0.90
p = 0.39
